The intent of the FY21 PRARP InCASA is to support innovative and impactful research that improves the quality of life and care for individuals, families, and care providers living with AD/ADRD.
The proposed work should innovatively challenge existing research paradigms or exhibit high levels of
creativity within the context of the PRARP’s mission and vision.
This can include innovations and research for symptom reduction (e.g., cognitive, behavioral, function, mood), resiliency factors, increasing or maintaining independence, and support for families and care providers.
The application should also demonstrate the study team’s experience in both military risk factor-related research and AD/ADRD as suited to the proposed work.
Given the patient-centered intent of the FY21 PRARP InCASA, animal research is prohibited.
The research innovation and impact for the FY21 PRARP InCASA are expected to benefit the military, Veteran, and civilian communities.
FY21 PRARP InCASA applications must be innovation- and impact-based.